Skip to main content

Fiscal Footnote: Senate Gift to Drug Maker

By ERIC LIPTON and KEVIN SACK The New York Times
Just two weeks after pleading guilty in a major federal fraud case, Amgen, the world's largest biotechnology firm, scored a largely unnoticed coup on Capitol Hill: Lawmakers inserted a paragraph into the "fiscal cliff" bill that did not mention the company by name but strongly favored one of its drugs.
Subscribe to Amgen